companydata.dkcompanydata.dk

NORDIC MEDICAL SOLUTIONS ApS: Financial statements 2023

CVR: 34352542

Source: annual report 2023, Danish Business Authority

01/07/2022 – 30/06/2023

NORDIC MEDICAL SOLUTIONS ApS (CVR 34352542) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 45,365,516 and a net result of DKK 11,529,644 compared with DKK 22,210,531 the year before. That is a decrease of 11.7% compared with the year before. Equity in the 2023 report amounted to DKK 22,029,644. The solvency ratio was 37.3%. The company had 14 employees in the financial year.

Gross Profit
DKK 45,365,516
Profit/Loss
DKK 11,529,644
Equity
DKK 22,029,644
Total Assets
DKK 58,991,828
Employees
14

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-45.4M11.5M22M14
2022-51.4M22.2M31.2M10
2021-55.7M35.3M41.3M8
2020-34.5M19.4M22.4M9
2019-34.3M19.9M22.9M8

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

About NORDIC MEDICAL SOLUTIONS ApS

NORDIC MEDICAL SOLUTIONS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NORDIC PHARMA SOLUTIONS ApS. The management consists of Pernille Wandrup Rex. The board consists of Kim Erik Ginnerup (chair), Monica Reib, Pernille Wandrup Rex and Philip Fischer Stavnstrup. The company is owned by NMS Group A/S. The company has 16 employees (2026). In 2026, the company reported a gross profit of DKK 56,510,150 and a net result of DKK 31,681,814 compared with DKK 28,614,955 the year before. Equity in the 2026 report amounted to DKK 40,681,814.

Source: annual report 2026, Danish Business Authority